Aquestive Therapeutics, Inc. (AQST) Return on equity
Aquestive Therapeutics, Inc. (AQST) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-608.9%FY2018
| Fiscal year | Value | YoY |
|---|---|---|
| FY2018 | -608.9% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More AQST financial trends
AQST RevenueAQST Net incomeAQST Net marginAQST Gross profitAQST Gross marginAQST Operating incomeAQST Operating marginAQST Operating cash flowAQST Free cash flowAQST Capital expendituresAQST Stock buybacksAQST Dividends paidAQST Total assetsAQST Total liabilitiesAQST Shareholders’ equityAQST overview →